Day One Biopharma Expands to ADCs with $55M Drug Acquisition by Lilu Anderson 19.06.2024 "Day One Biopharmaceuticals enhances pipeline, acquiring global rights to promising PTK7-targeting cancer drug DAY301, begins trial soon."